In-Vitro Diagnostics Market, By Product (Instruments, Reagents & Kits, and Software & Services), By Technology, By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV1061
|
Published Date
January 2026
|
Pages
387
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
In-Vitro Diagnostics Market size was valued at US$ 109,210.20 Million in 2024, expanding at a CAGR of 5.84% from 2025 to 2032.
The In-Vitro Diagnostics (IVD) market encompasses medical tests performed on biological samples—such as blood, urine, saliva, and tissue—to detect diseases, confirm diagnoses, monitor treatment responses, and support routine screening. This market includes test reagents and kits, laboratory and point-of-care instruments, as well as software for reporting, connectivity, and workflow management. IVD testing plays a critical role in healthcare by supporting clinical decision-making across key areas, including infectious disease management, oncology, cardiometabolic monitoring, and autoimmune disorders. IVD tests are utilized in hospitals, independent laboratories, clinics, and, increasingly, home-based settings.
Market growth is driven by long-term healthcare trends such as the rising prevalence of chronic diseases, aging populations, and the global shift toward earlier diagnosis and preventive care. There is also increasing demand for faster, more accessible testing, which has fueled interest in point-of-care solutions and decentralized testing models, particularly in situations requiring rapid results for triage and treatment decisions. Advances in molecular diagnostics, syndromic testing, and companion diagnostics are further enhancing the clinical value of IVD by improving disease detection, supporting targeted therapies, and enabling personalized treatment pathways.
In-Vitro Diagnostics Market- Market Dynamics
Rising Prevalence of Chronic Diseases Drives Demand for Routine Laboratory Testing
A key driver of the In-Vitro Diagnostics (IVD) market is the rising burden of chronic diseases, which necessitate continuous screening and long-term monitoring through routine laboratory testing. This creates consistent demand for high-volume assays such as HbA1c, glucose, lipid panels, kidney function tests, and cardiac biomarkers. According to the International Diabetes Federation (IDF), 537 million adults aged 20–79 were living with diabetes in 2021, with global diabetes-related healthcare spending reaching approximately USD 966 billion, highlighting both the scale and cost of the disease and the resulting structurally high testing volumes. The United States further illustrates sustained diagnostic demand. As reported by the Centers for Disease Control and Prevention (CDC), 38.4 million Americans (around 11.6% of the population) had diabetes in 2021, with an additional 8.7 million adults undiagnosed—underscoring the ongoing need for screening and confirmatory testing in laboratories and primary care settings.
Cardiovascular diseases (CVD) also drive routine testing across clinical chemistry and immunoassay categories. The World Health Organization (WHO) reports that CVDs account for approximately 17.9 million deaths annually, emphasizing the importance of early risk detection and hospital-based diagnostics. Together, these statistics demonstrate why chronic conditions generate sustained demand for IVD testing: management of these diseases requires repeated testing over many years, making repeat diagnostic cycles a structural feature of the market rather than a one-time need.
In-Vitro Diagnostics Market- Segmentation Analysis:
The demand for In-Vitro Diagnostics (IVD) is strongly driven by the ongoing need for molecular testing in infectious disease management and the substantial, repeat-testing burden associated with diabetes monitoring. Molecular diagnostics remain critical because rapid and accurate pathogen detection informs treatment decisions, supports infection control, and enables public health surveillance. The COVID19 pandemic highlighted the scale of testing required for effective disease monitoring: according to the World Health Organization (WHO), cumulative global confirmed COVID19 cases surpassed 760 million by 2023, illustrating the massive and sustained testing demand that health systems had to manage over multiple years.
At the same time, diabetes continues to generate steady laboratory utilization, as disease management relies on routine measurements such as glucose and HbA1c over extended periods. In the United States, the Centers for Disease Control and Prevention (CDC) reported that 38.4 million people (approximately 11.6% of the population) had diabetes in 2021, with an additional 8.7 million adults undiagnosed, creating ongoing demand for screening and confirmatory testing. Globally, the burden is even greater: the International Diabetes Federation (IDF) estimated that 537 million adults aged 20–79 were living with diabetes in 2021, maintaining high-volume routine testing as a consistent driver for laboratory workflows, consumable usage, and overall IVD market growth.
In-Vitro Diagnostics Market- Geographical Insights
The IVD market is strongest in regions with high healthcare utilization, well-established reimbursement systems, and extensive laboratory networks capable of efficiently processing large test volumes. North America and Europe continue to lead due to consistent routine testing for chronic conditions and relatively high adoption of advanced diagnostics. Meanwhile, the Asia Pacific region is experiencing rapid growth as access to diagnostic services improves and hospital capacity expands. Infectious disease surveillance can also drive significant testing volumes during outbreaks. For example, the World Health Organization (WHO) reported that cumulative global COVID19 confirmed cases exceeded 760 million by 2023, demonstrating how quickly molecular and immunoassay testing can scale when public health systems require widespread monitoring. At the same time, chronic diseases create a stable, long-term base of demand across all regions. According to the International Diabetes Federation (IDF), 537 million adults aged 20–79 were living with diabetes in 2021, driving continuous demand for routine laboratory tests used for ongoing disease management and monitoring of complications.
United States In-Vitro Diagnostics Market- Country Insights
The United States represents the largest single-country market for In-Vitro Diagnostics (IVD) due to high testing utilization and widespread adoption of advanced diagnostic platforms across hospitals and large independent laboratories. A substantial chronic disease population generates predictable, repeat testing requirements. According to the Centers for Disease Control and Prevention (CDC), 38.4 million people in the U.S. had diabetes in 2021 (approximately 11.6% of the population), with an additional 8.7 million adults undiagnosed. This underscores the ongoing need for screening and long-term monitoring across primary care and laboratory settings. In addition, public health surveillance and outbreak response drive demand for molecular testing capabilities with rapid turnaround times, ensuring that procurement decisions remain focused on throughput, reliability, and supply continuity.
In-Vitro Diagnostics Market- Competitive Landscape:
The IVD market is led by global diagnostics manufacturers and supported by large laboratory service providers, with competition primarily driven by test menu breadth, automation, turnaround time, instrument uptime, and cost per reportable result. F. Hoffmann-La Roche Ltd and Abbott Laboratories are recognized for their broad portfolios spanning immunoassay, clinical chemistry, and point-of-care testing, supported by extensive installed bases. Siemens Healthineers AG and Danaher Corporation are noted for high-throughput laboratory systems and automation solutions, which are critical for large hospitals and reference laboratories managing peak testing volumes. Thermo Fisher Scientific Inc. and QIAGEN N.V. are associated with molecular diagnostics capabilities, particularly for infectious and specialized testing, while bioMérieux SA is prominent in microbiology and infectious disease diagnostics, and Sysmex Corporation focuses on hematology workflows. Laboratory Corporation of America Holdings and Quest Diagnostics Incorporated are recognized for their strengths in large-scale laboratory operations, logistics, and national testing capacity. Across all these vendors, competitive advantages generally stem from the size of the installed base, service coverage, reagent supply security, software connectivity, and proven performance during periods of high demand, as exemplified by the surge in testing during the COVID-19 pandemic, when global case volumes stressed health systems worldwide.
Recent Developments:
- November 2024: The Department of Pharmaceuticals, Government of India launched the Scheme for Strengthening the Medical Device Industry with a total outlay of 500 crore. The initiative focuses on common infrastructure, reducing import dependence for key components, skill development, clinical study support, and promotion activities. The agency also highlighted that India’s medical device market is valued at approximately $14 billion and is projected to reach $30 billion by 2030.
- May 2025: The World Health Organization (WHO) supported Nepal in launching a National Essential In-vitro Diagnostics List (NEIDL). Through The Pandemic Fund, WHO provided laboratory equipment and reagents, including a Class III Biosafety Cabinet, calibration equipment for the National Public Health Laboratory, and microbiology tools for distribution to 25 local and provincial hospitals to expand bacterial culture, antibiotic sensitivity testing, and strengthen AMR surveillance and outbreak response.
- July 2025: The Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom announced plans to modernize access to medical technologies in Great Britain. Key measures include introducing international reliance routes using approvals from trusted regulators in Australia, Canada, and the U.S., indefinite recognition of CE-marked devices, and removing the requirement for physical UKCA markings once UDI requirements are implemented, aimed at reducing regulatory duplication and improving patient access to innovative technologies.
- December 2025: Vall d\'Hebron University Hospital and Vall d’Hebron Research Institute (VHIR) in Spain signed a collaboration with Viva In-Vitro Diagnostics to conduct a clinical study on functional detection of the NLRP3 inflammasome as a sepsis biomarker. The study plans to enroll at least 280 patients and 80 healthy controls to support clinical validation of the VIVAELISA® assay for prognosis and immune stratification.
- August 2025: The WHO released a target product profile to guide the development of IVD tests for serious bacterial infections in newborns and young infants, including neonatal sepsis. Globally, an estimated 2.3 million newborns die each year, with roughly 15% of deaths linked to sepsis, and evidence suggests that 84% of infection-related newborn deaths could be prevented through early diagnosis and appropriate clinical management.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL In-Vitro Diagnostics MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- Becton, Dickinson and Company
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Danaher Corporation
- DiaSorin S.p.A.
- F. Hoffmann-La Roche Ltd
- Hologic, Inc.
- Illumina, Inc.
- Laboratory Corporation of America Holdings
- Ortho Clinical Diagnostics, Inc.
- QIAGEN N.V.
- Quest Diagnostics Incorporated
- QuidelOrtho Corporation
- Roche Diagnostics International AG
- Seegene Inc.
- Siemens Healthineers AG
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- Others
GLOBAL In-Vitro Diagnostics MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032
- Instruments
- Reagents & Kits
- Software & Services
GLOBAL In-Vitro Diagnostics MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Immunoassays
- Clinical Chemistry
- Molecular Diagnostics
- Hematology
- Microbiology
- Coagulation & Hemostasis
- Point-of-Care (POC) Testing
GLOBAL In-Vitro Diagnostics MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Infectious Diseases
- Oncology
- Cardiology
- Diabetes
- Autoimmune Diseases
- Nephrology
- Other Applications
GLOBAL In-Vitro Diagnostics MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Clinical Laboratories
- Point-of-Care Settings
- Homecare
- Others
GLOBAL In-Vitro Diagnostics MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. In-Vitro Diagnostics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. In-Vitro Diagnostics Market Snippet by Product
2.1.2. In-Vitro Diagnostics Market Snippet by Technology
2.1.3. In-Vitro Diagnostics Market Snippet by Application
2.1.4. In-Vitro Diagnostics Market Snippet by End User
2.1.5. In-Vitro Diagnostics Market Snippet by Country
2.1.6. In-Vitro Diagnostics Market Snippet by Region
2.2. Competitive Insights
3. In-Vitro Diagnostics Key Market Trends
3.1. In-Vitro Diagnostics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. In-Vitro Diagnostics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. In-Vitro Diagnostics Market Opportunities
3.4. In-Vitro Diagnostics Market Future Trends
4. In-Vitro Diagnostics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. In-Vitro Diagnostics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. In-Vitro Diagnostics Market Landscape
6.1. In-Vitro Diagnostics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. In-Vitro Diagnostics Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
7.1.2. Instruments
7.1.3. Reagents & Kits
7.1.4. Software & Services
8. In-Vitro Diagnostics Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
8.1.2. Immunoassays
8.1.3. Clinical Chemistry
8.1.4. Molecular Diagnostics
8.1.5. Hematology
8.1.6. Microbiology
8.1.7. Coagulation & Hemostasis
8.1.8. Point-of-Care (POC) Testing
9. In-Vitro Diagnostics Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
9.1.2. Infectious Diseases
9.1.3. Oncology
9.1.4. Cardiology
9.1.5. Diabetes
9.1.6. Autoimmune Diseases
9.1.7. Nephrology
9.1.8. Other Applications
10. In-Vitro Diagnostics Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
10.1.2. Hospitals
10.1.3. Clinical Laboratories
10.1.4. Point-of-Care Settings
10.1.5. Homecare
10.1.6. Others
11. In-Vitro Diagnostics Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. In-Vitro Diagnostics Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. In-Vitro Diagnostics Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. In-Vitro Diagnostics Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. In-Vitro Diagnostics Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. In-Vitro Diagnostics Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- In-Vitro Diagnostics Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Abbott Laboratories
12.2.2. Becton, Dickinson and Company
12.2.3. bioMérieux SA
12.2.4. Bio-Rad Laboratories, Inc.
12.2.5. Bruker Corporation
12.2.6. Danaher Corporation
12.2.7. DiaSorin S.p.A.
12.2.8. F. Hoffmann-La Roche Ltd
12.2.9. Hologic, Inc.
12.2.10. Illumina, Inc.
12.2.11. Laboratory Corporation of America Holdings
12.2.12. Ortho Clinical Diagnostics, Inc.
12.2.13. QIAGEN N.V.
12.2.14. Quest Diagnostics Incorporated
12.2.15. QuidelOrtho Corporation
12.2.16. Roche Diagnostics International AG
12.2.17. Seegene Inc.
12.2.18. Siemens Healthineers AG
12.2.19. Sysmex Corporation
12.2.20. Thermo Fisher Scientific Inc.
12.2.21. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL In-Vitro Diagnostics MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- Becton, Dickinson and Company
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Danaher Corporation
- DiaSorin S.p.A.
- F. Hoffmann-La Roche Ltd
- Hologic, Inc.
- Illumina, Inc.
- Laboratory Corporation of America Holdings
- Ortho Clinical Diagnostics, Inc.
- QIAGEN N.V.
- Quest Diagnostics Incorporated
- QuidelOrtho Corporation
- Roche Diagnostics International AG
- Seegene Inc.
- Siemens Healthineers AG
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- Others
GLOBAL In-Vitro Diagnostics MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032
- Instruments
- Reagents & Kits
- Software & Services
GLOBAL In-Vitro Diagnostics MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Immunoassays
- Clinical Chemistry
- Molecular Diagnostics
- Hematology
- Microbiology
- Coagulation & Hemostasis
- Point-of-Care (POC) Testing
GLOBAL In-Vitro Diagnostics MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Infectious Diseases
- Oncology
- Cardiology
- Diabetes
- Autoimmune Diseases
- Nephrology
- Other Applications
GLOBAL In-Vitro Diagnostics MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Clinical Laboratories
- Point-of-Care Settings
- Homecare
- Others
GLOBAL In-Vitro Diagnostics MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
